The Mark Foundation for Cancer Research and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) announced today a new $10 million commitment at The Johns Hopkins University to fund novel work and advance immunotherapy research to provide lifesaving breakthroughs to people with cancer. Immunotherapy drugs — more than all other cancer drugs approved in the last decade — are now becoming first-line therapies.
Concept Cloud